Glucan Corp., #305 Marine Bio-Industry Development Center, Hoenggye-ri 27, Ilgwang-myeon, Gijan-gun, Busan, 46048, Republic of Korea.
Department of Anatomy and Histology, College of Korean Medicine, Daegu Haany University, 290 Yugok-dong, Gyeongsan-si, Gyeongsanbuk-do, 38610, Republic of Korea.
BMC Complement Altern Med. 2019 Feb 20;19(1):49. doi: 10.1186/s12906-019-2457-0.
Hordeum vulgare L (barley) contains numerous phenolic substances with proven anticancer, antioxidant and gastroprotective activities. Saccharification increases the functionality and bioavailability of these compounds thus can aid in the development of a natural product based medicine. This study aimed to investigate the possible gastroprotective effects of saccharification on the indomethacin (IND)-induced gastric ulcers in rats using Weissella cibaria- and Saccharomyces cerevisiae-triple fermented H. vulgare extract (FBe).
In total, 60 healthy male 6-week old Sprague-Dawley SD (SPF/VAF Outbred CrljOri:CD1) rats were commercially purchased. The FBe extract (100, 200, and 300 mg kg) was orally administered 30 min before an oral treatment of IND (25 mg kg). Six hours after IND treatment, variations in the histopathology, myeloperoxidase (MPO) activity, gross lesion scores, lipid peroxidation, and antioxidant defense system component (superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH)) levels were measured.
FBe treatment showed significant (p < 0.01 or p < 0.05) and dose-dependent decrease in gastric mucosal damage. In the present study hemorrhagic gross lesions, gastric MPO activity, and histopathological gastric ulcerative lesions were observed in IND-treated rats compared to the IND control rats. In particular, FBe, in a dose-dependent manner, strengthened the antioxidant defense systems, decreased lipid peroxidation and CAT activity by increasing the GSH levels and SOD activity, respectively. The 200 mg kg dose of FBe was similarly gastroprotective as the 10 mg kg dose of omeprazole in rats with IND-induced gastric mucosal damage.
The findings of the present study show that an oral administration of FBe had positive gastroprotective effects through strengthening the body antioxidant defense system and anti-inflammatory effects.
普通大麦(大麦)含有许多具有抗癌、抗氧化和胃保护作用的酚类物质。糖化作用提高了这些化合物的功能和生物利用度,因此有助于开发基于天然产物的药物。本研究旨在通过使用 Weissella cibaria 和 Saccharomyces cerevisiae 三重发酵的大麦提取物(FBe)研究糖化对吲哚美辛(IND)诱导的大鼠胃溃疡的可能胃保护作用。
总共购买了 60 只健康的雄性 6 周龄 Sprague-Dawley SD(SPF/VAF 远交 CrljOri:CD1)大鼠。FBe 提取物(100、200 和 300mg/kg)在口服 IND(25mg/kg)前 30 分钟口服给药。IND 处理后 6 小时,测量组织病理学变化、髓过氧化物酶(MPO)活性、大体损伤评分、脂质过氧化和抗氧化防御系统成分(超氧化物歧化酶(SOD)、过氧化氢酶(CAT)和谷胱甘肽(GSH))水平的变化。
FBe 处理显示出显著(p<0.01 或 p<0.05)和剂量依赖性的胃黏膜损伤减少。在本研究中,与 IND 对照大鼠相比,IND 处理大鼠观察到出血性大体损伤、胃 MPO 活性和组织病理学胃溃疡病变。特别是,FBe 以剂量依赖性方式增强抗氧化防御系统,通过增加 GSH 水平和 SOD 活性分别降低脂质过氧化和 CAT 活性。与 IND 诱导的胃黏膜损伤大鼠中 10mg/kg 剂量的奥美拉唑相比,FBe 的 200mg/kg 剂量具有相似的胃保护作用。
本研究的结果表明,FBe 的口服给药通过增强机体抗氧化防御系统和抗炎作用具有积极的胃保护作用。